Related Experiment Video
Updated: Feb 21, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Meropenem Induced Hypokalemia
T V Anuhya1, Raviraj Acharya2, Sharath MadhyasthaA2
1Postgraduate, Department of Pharmacology, KMC, Manipal University, Udupi, Karnataka, India.
Abstract:
Meropenam, a beta-lactam antibiotic has been used for severe infections of skin, tissue, intra- abdominal and urogenital infections in hospitalized patients. The common adverse effects reported are diarrhoea, vomiting, rashes and hypersensitivity reactions. Here we report two cases of meropenam induced hypokalemia, wherein, meropenam was prescribed for cellulitis and urinary tract infection in the first and second case respectively. Hypokalemia can manifest as muscular weakness, fatigue, muscle cramps, constipation, ileus, flaccid paralysis, hyporeflexia, hypercapnia, tetany, rhabdomyolysis or respiratory failure. Hence, it is necessary to make physicians aware of such an adverse effect which can develop with meropenam.
Insights
Meropenam, a broad-spectrum antibiotic, can cause hypokalemia (low potassium). This rare adverse effect requires physician awareness, especially in patients with cellulitis or urinary tract infections.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Medicine
Background:
- Meropenam is a carbapenem antibiotic used for severe bacterial infections.
- Commonly reported side effects include gastrointestinal issues and hypersensitivity.
- Its potential to induce electrolyte disturbances is less documented.
Observation:
- Two hospitalized patients developed hypokalemia during meropenam treatment.
- Case 1: Meropenam prescribed for cellulitis.
- Case 2: Meropenam prescribed for urinary tract infection.
Findings:
- Meropenam administration was associated with the development of hypokalemia in both cases.
- Hypokalemia presents with a range of symptoms, from muscle weakness to respiratory failure.
- This highlights a potential, under-recognized adverse drug reaction.
Implications:
- Physicians should consider meropenam-induced hypokalemia in patients presenting with compatible symptoms.
- Monitoring potassium levels may be warranted in certain patient populations receiving meropenam.
- Increased awareness can prevent delayed diagnosis and management of this adverse effect.
More Related Videos
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Acute Kidney Injury V: Interprofessional Care
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Hemodialysis II: Procedure and Complications
Heart Failure Drugs: Diuretics
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

